China Pharma Holdings (CPHI) Interest & Investment Income (2016 - 2025)
Historic Interest & Investment Income for China Pharma Holdings (CPHI) over the last 17 years, with Q3 2025 value amounting to $294.0.
- China Pharma Holdings' Interest & Investment Income fell 7986.3% to $294.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3125.0, marking a year-over-year decrease of 6012.0%. This contributed to the annual value of $6641.0 for FY2024, which is 59.07% up from last year.
- Latest data reveals that China Pharma Holdings reported Interest & Investment Income of $294.0 as of Q3 2025, which was down 7986.3% from $422.0 recorded in Q2 2025.
- In the past 5 years, China Pharma Holdings' Interest & Investment Income registered a high of $6655.0 during Q1 2022, and its lowest value of $294.0 during Q3 2025.
- For the 5-year period, China Pharma Holdings' Interest & Investment Income averaged around $1517.0, with its median value being $1240.0 (2022).
- In the last 5 years, China Pharma Holdings' Interest & Investment Income soared by 153916.26% in 2022 and then tumbled by 8575.51% in 2023.
- Quarter analysis of 5 years shows China Pharma Holdings' Interest & Investment Income stood at $1412.0 in 2021, then dropped by 28.97% to $1003.0 in 2022, then surged by 152.24% to $2530.0 in 2023, then plummeted by 47.23% to $1335.0 in 2024, then crashed by 77.98% to $294.0 in 2025.
- Its Interest & Investment Income stands at $294.0 for Q3 2025, versus $422.0 for Q2 2025 and $1074.0 for Q1 2025.